Mylan N.V. stock price

Mylan N.V. latest news:


  • 01/03/2018 15:40:41

    Momenta, Mylan plan trial of biosimilar to Regeneron eye drug

    Jan 3 (Reuters) - Momenta Pharmaceuticals Inc and Mylan NV plan to begin a pivotal clinical trial of a biosimilar to Regeneron Pharmaceuticals Inc's blockbuster eye drug Eylea in the first half of this year, the two companies said on Wednesday.

  • 12/29/2017 08:52:13

    BRIEF-Mylan Announces FDA Approval Of First Generic For Estrace Cream

    Mylan Nv(MYL): * MYLAN ADDS TO U.S. WOMEN'S HEALTHCARE PORTFOLIO WITH FDA APPROVAL OF FIRST GENERIC FOR ESTRACEĀ® CREAM. * Mylan Nv (MYL)- ANNOUNCED U.S. LAUNCH OF ESTRADIOL VAGINAL CREAM USP, 0.01%, FIRST GENERIC VERSION OF ALLERGAN'S ESTRACE CREAM Source text for Eikon: Further company coverage:

  • 11/30/2017 15:29:20

    Mylan shares jump after report Amazon is in talk with generic drug makers

    Shares of drugmaker Mylan NV shot up in the extended session Thursday after a CNBC report that Amazon.com Inc. was holding preliminary talks with generic drugmakers -- including Mylan and Novartis AG unit Sandoz -- as it contemplates entering the pharmacy business. CNBC reported that the talks were high-level, but said Amazon's plans were still not clear. Mylan shares were last up 4.5% after hours, after closing down 0.9%; Novartis shares were up slightly after hours. Speculation about Amazon's entry into the pharmacy business has weighed on pharmaceutical middlemen stocks in recent months. As MarketWatch has reported, Amazon's entry into the field could also have major implications for consumers.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    MYOS CorporationMYOS | MYR Group, Inc.MYRG | Myriad Genetics, Inc.MYGN | Nanometrics IncorporatedNANO | Nanosphere, Inc.NSPH | NanoString Technologies, Inc.NSTG | NantKwest, Inc.NK | NAPCO Security Technologies, Inc.NSSC | search, Inc.NDAQ | Natera, Inc.NTRA |